Atlas Trials

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

Clinical trial NCT03879122 · UNKNOWN

Trial details

NCT number
NCT03879122
Sponsor
Spanish Oncology Genito-Urinary Group
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Metastatic Hormone-sensitive Prostate Cancer
Start date
2019-02-11
Primary completion
2023-07-31
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.